This Article Full Text Full Text (PDF) All Versions of this Article: 111/14/1784    most recent 01.CIR.0000160863.30496.9Bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vallbracht, K. B. Articles by Schultheiss, H.-P. Search for Related Content PubMed PubMed Citation Articles by Vallbracht, K. B. Articles by Schultheiss, H.-P. Pubmed/NCBI databases Medline Plus Health Information Cardiomyopathy Related Collections Other myocardial biology Myocardial cardiomyopathy disease Coronary imaging: angiography/ultrasound/Doppler/CC Coronary circulation Endothelium/vascular type/nitric oxide

(Circulation. 2005;111:1784-1791.)
© 2005 American Heart Association, Inc.

Heart Failure

Differential Aspects of Endothelial Function of the Coronary Microcirculation Considering Myocardial Virus Persistence, Endothelial Activation, and Myocardial Leukocyte Infiltrates

Katja B. Vallbracht, MD; Peter L. Schwimmbeck, MD; Uwe Kühl, MD, PhD; Ursula Rauch, MD; Bettina Seeberg, MD; Heinz-Peter Schultheiss, MD

From Charité Medical University Berlin, Berlin, Germany.

Correspondence to Dr Med Katja B. Vallbracht, Charité Medical University Berlin, Campus Benjamin Franklin, Department of Cardiology, Hindenburgdamm 30, 12200 Berlin, Germany. E-mail katja.vallbracht-israng{at}charite.de

Received July 9, 2004; revision received December 1, 2004; accepted December 27, 2004.

Background— Viral cardiomyopathy resulting from myocardial virus persistence can be associated with inflammatory immune responses that involve the myocardium and coronary blood vessels. The aim of this study was to investigate the differential impact of myocardial virus persistence and inflammation on endothelial function of the coronary microcirculation.

Methods and Results— In 71 patients with nonischemic cardiomyopathy, myocardial biopsies were examined for virus persistence (by polymerase chain reaction) and inflammation (by immunohistology). Endothelial function of the coronary microcirculation was examined during heart catheterization by measuring diameter (by quantitative coronary angiography) and velocity changes (by intracoronary Doppler) of the left anterior descending artery in response to acetylcholine. Coronary blood flow (CBF) was calculated. Endothelium-independent vasoreactivity to adenosine was assessed. Mean age of the patients (37 men, 34 women) was 43±13 years; mean ejection fraction was 64±11%. In 43 patients, adenovirus, enterovirus, parvovirus, or HHV-6 was detected; 28 had no virus. Endothelial function of the coronary microcirculation was significantly impaired in patients with myocardial virus persistence (V) compared with patients without virus (Co) (CBF-V, 22±86%; CBF-Co, 110±113%; P=0.001), which was confirmed in 51 patients with myocardial inflammation (MC) (32 with virus, 19 with no virus) (CBF-MC-V, 12±89%; CBF-MC-Co, 81±109%; P=0.034) and in 20 patients with normal immunohistology of the myocardial biopsies (Co) (11 with virus, 9 with no virus) (CBF-Co-V, 51±72%; CBF-Co-Co, 175±97%; P=0.006). Endothelial function of the coronary microcirculation was also significantly impaired in patients with myocardial inflammation/endothelial activation compared with patients without inflammatory immune response. Endothelium-independent vasodilation was not influenced significantly.

Conclusions— Myocardial virus persistence and myocardial inflammation/endothelial activation are associated with endothelial dysfunction of the coronary microcirculation. Endothelial dysfunction in patients with myocardial virus persistence can occur independently of myocardial inflammation/endothelial activation but is more pronounced in patients with concurrent inflammation.

Key Words: cardiomyopathy • microcirculation • endothelium • inflammation • viruses

This article has been cited by other articles:

				M Comar, P D'Agaro, C Campello, A Poli, J P Breinholt III, J A Towbin, and M Vatta Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease J. Clin. Pathol., January 1, 2009; 62(1): 80 - 83. [Abstract] [Full Text] [PDF]

				A Yilmaz, H Mahrholdt, A Athanasiadis, H Vogelsberg, G Meinhardt, M Voehringer, E-M Kispert, C Deluigi, H Baccouche, E Spodarev, et al. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis Heart, November 1, 2008; 94(11): 1456 - 1463. [Abstract] [Full Text] [PDF]

				A. Yilmaz, K. Klingel, R. Kandolf, and U. Sechtem A geographical mystery: do cardiotropic viruses respect national borders? J. Am. Coll. Cardiol., July 1, 2008; 52(1): 82 - 82. [Full Text] [PDF]

				L. Andreoletti Reply. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 82 - 83. [Full Text] [PDF]

				A Abbate, R Bussani, G Liuzzo, G G L Biondi-Zoccai, E Barresi, P Mellone, G Sinagra, A Dobrina, F De Giorgio, R Sharma, et al. Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation Heart, June 1, 2008; 94(6): 737 - 742. [Abstract] [Full Text] [PDF]

				L. van Heerebeek, N. Hamdani, M. L. Handoko, I. Falcao-Pires, R. J. Musters, K. Kupreishvili, A. J.J. Ijsselmuiden, C. G. Schalkwijk, J. G.F. Bronzwaer, M. Diamant, et al. Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension Circulation, January 1, 2008; 117(1): 43 - 51. [Abstract] [Full Text] [PDF]

				A. Saraste, V. Kyto, M. Saraste, T. Vuorinen, J. Hartiala, and P. Saukko Coronary flow reserve and heart failure in experimental coxsackievirus myocarditis. A transthoracic Doppler echocardiography study Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H871 - H875. [Abstract] [Full Text] [PDF]